Coltene Holding Net Income Over Time
| CLTN Stock | CHF 54.20 0.30 0.55% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Coltene Holding Performance and Coltene Holding Correlation. Coltene |
Cross Equities Net Income Analysis
Compare Coltene Holding AG and related stocks such as IVF Hartmann Holding, Newron Pharmaceuticals, and DocMorris AG Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VBSN | 3.3 M | 13.2 M | 14.8 M | 15.3 M | 15.8 M | 16.1 M | 16.4 M | 16 M | 14.1 M | 12.2 M | 17.8 M | 6.2 M | 11.2 M | 15.1 M | 20.3 M | 23.3 M | 12.7 M |
| NWRN | (14.9 M) | (6.4 M) | (2.4 M) | (7.1 M) | (10.1 M) | (22.8 M) | (15.2 M) | (5.3 M) | (15 M) | (20.2 M) | (21 M) | (14.9 M) | (17.5 M) | (16.2 M) | 15.8 M | 18.2 M | 19.1 M |
| DOCM | 3.9 M | 8.7 M | 6.2 M | (15.5 M) | 7.2 M | 3.4 M | (12.8 M) | (36.2 M) | (39 M) | (52.4 M) | (135.7 M) | (225.7 M) | (171.1 M) | 82.3 M | (97.3 M) | (87.5 M) | (83.2 M) |
| ASCN | (67.8 M) | 23.1 M | 20.9 M | 36.9 M | 38.5 M | 24.3 M | (145.7 M) | 25.9 M | 21.4 M | 500 K | 6.5 M | 13.5 M | 11 M | 17.4 M | 3.7 M | 3.3 M | 3.2 M |
| SANN | (28.3 M) | (27.8 M) | (31.4 M) | (5.8 M) | (7.5 M) | 5.9 M | (35.4 M) | (51.5 M) | (54.2 M) | (19 M) | (67.7 M) | (55.5 M) | (71.1 M) | 54.8 M | (42 M) | (37.8 M) | (39.7 M) |
| MOLN | 7.1 M | 7.1 M | 7.1 M | 7.1 M | (2.3 M) | (148.8 K) | (18.6 M) | (25.4 M) | (37 M) | (36.3 M) | (62.8 M) | (63.8 M) | 117.9 M | (62 M) | (54 M) | (48.6 M) | (46.2 M) |
| SHLTN | 1.4 M | 4 M | (7.3 M) | 2.2 M | 829 K | (16.6 M) | (11.1 M) | 2.4 M | 10.1 M | 5.7 M | 278 K | (14.1 M) | (76 K) | (7.1 M) | (28.1 M) | (25.3 M) | (24 M) |
| ADXN | (20.5 M) | (31.1 M) | (27 M) | (14.5 M) | (1.8 M) | (4.2 M) | (3.1 M) | (3.3 M) | (1.6 M) | (14.8 M) | (12.9 M) | (15.4 M) | (20.8 M) | (10.6 M) | 7.1 M | 8.1 M | 8.5 M |
| BSLN | (59 M) | (57.6 M) | (53 M) | (33 M) | (41.5 M) | (61.6 M) | (51.3 M) | (19.4 M) | (31.4 M) | (22.4 M) | (14.7 M) | (6.8 M) | 12.1 M | 10.5 M | 77.6 M | 89.2 M | 93.7 M |
Coltene Holding AG and related stocks such as IVF Hartmann Holding, Newron Pharmaceuticals, and DocMorris AG Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Coltene Holding AG financial statement analysis. It represents the amount of money remaining after all of Coltene Holding AG operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| Coltene Holding AG | CLTN |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | Feldwiesenstrasse 20, Altsttten, |
| Exchange | SIX Swiss Exchange |
CHF 54.2
Additional Tools for Coltene Stock Analysis
When running Coltene Holding's price analysis, check to measure Coltene Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coltene Holding is operating at the current time. Most of Coltene Holding's value examination focuses on studying past and present price action to predict the probability of Coltene Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coltene Holding's price. Additionally, you may evaluate how the addition of Coltene Holding to your portfolios can decrease your overall portfolio volatility.